U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07248163) titled 'Universal CAR-T Cell Therapy for NHL' on Nov. 18.
Brief Summary: This is a single-center, single-arm, open-label clinical study, and the sample size is set to 3-6 subjects.
Study Start Date: March 11
Study Type: INTERVENTIONAL
Condition:
Non-hodgkin Lymphoma,B Cell
Intervention:
DRUG: BRL-301
The administered dose is 5x10^6/kg
Recruitment Status: RECRUITING
Sponsor: Bioray Laboratories
Published by HT Digital Content Services with permission from Health Daily Digest....